Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery is a research paper published in Cell Reports Medicine (2022). On theSindex it has a DataRank of 0.606. It has been cited 56 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.606
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Stiftung Schleswig-Holsteinische Landesmuseen
Grant: DIO002 /CoVispecT
National Institute of Allergy and Infectious Diseases
Grant: F32AI157296
Deutsche Forschungsgemeinschaft
Grant: DFG 433038070
Deutsche Forschungsgemeinschaft
Grant: DFG 4096610003
NIAID NIH HHS
Grant: R01 AI136514
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5F32AI157296-03
Investigating the cellular responses to influenza virus infection and the origins of first exposure immune imprinting
National Institutes of Health
Grant: 5R01AI136514-05
Decoding the interactions between T cell receptors and peptide-MHC
Deutsche Forschungsgemeinschaft
Johnson and Johnson
Israel National Road Safety Authority
NIH
Miltenyi Biotec
FWCI
5.02
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals